69315-404 : Varenicline TartrateVarenicline Tartrate Kit


NDC: 69315-404
Labeler: Leading Pharma, LLC
Product Type: Human Prescription Drug
Drug Name:  Varenicline Tartrate
Dosage Form: Kit
Application #: ANDA217151
Rev. Date: 


NDC Package Codes:

  • 69315-404-57: 1 KIT IN 1 BOX (69315‑404‑57) * 11 TABLET, FILM COATED IN 1 BLISTER PACK * 42 TABLET, FILM COATED IN 1 BLISTER PACK

Related Products:

Based on records with the same trade name.
  • 69315-402 Varenicline Tartrate .5 mg/561 Oral Tablet, Film Coated by Leading Pharma, LLC
  • 69315-403 Varenicline Tartrate 1 mg/561 Oral Tablet, Film Coated by Leading Pharma, LLC
  • 42934-104 Varenicline Tartrate .5 mg/561 Oral Tablet, Film Coated by Medley Pharmaceuticals Limited
  • 42934-105 Varenicline Tartrate 1 mg/561 Oral Tablet, Film Coated by Medley Pharmaceuticals Limited
  • 42934-106 Varenicline TartrateVarenicline Tartrate Oral Kit by Medley Pharmaceuticals Limited
  • 68462-893 Varenicline Tartrate .5 mg Oral Tablet, Film Coated by Glenmark Pharmaceuticals Inc., USA
  • 68462-894 Varenicline Tartrate 1 mg Oral Tablet, Film Coated by Glenmark Pharmaceuticals Inc., USA
  • 68462-895 Varenicline TartrateVarenicline Tartrate Kit by Glenmark Pharmaceuticals Inc., USA
  • 70748-125 Varenicline TartrateVarenicline Tartrate Kit by Lupin Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69315-404 QR Code

< Prev: 69315-403Next: 69315-501 >

Related Discussions:

effexor interaction varenicline
I am considering taking champix to quit smoking and need to know if there are any drug interactions with effexor and mic... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.